Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
INDV similar filings
- 28 Feb 25 Director/pdmr Shareholding
- 28 Feb 25 Holding(s) In Company
- 27 Feb 25 Director/pdmr Shareholding
- 27 Feb 25 Director/pdmr Shareholding
- 27 Feb 25 Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer
- 25 Feb 25 Holding(s) In Company
- 24 Feb 25 Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection
Filing view
External links